IAM
ALXN
Impax Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q1 | – | Sell |
-1,049
| Closed | -$200K | – | 212 |
|
2015
Q4 | $200K | Buy |
+1,049
| New | +$200K | 0.01% | 191 |
|
2015
Q3 | – | Sell |
-8,415
| Closed | -$1.52M | – | 201 |
|
2015
Q2 | $1.52M | Buy |
8,415
+7
| +0.1% | +$1.27K | 0.08% | 149 |
|
2015
Q1 | $1.46M | Sell |
8,408
-1,621
| -16% | -$281K | 0.08% | 154 |
|
2014
Q4 | $1.86M | Buy |
10,029
+60
| +0.6% | +$11.1K | 0.11% | 149 |
|
2014
Q3 | $1.65M | Sell |
9,969
-95
| -0.9% | -$15.8K | 0.11% | 142 |
|
2014
Q2 | $1.57M | Hold |
10,064
| – | – | 0.1% | 142 |
|
2014
Q1 | $1.53M | Buy |
10,064
+2
| +0% | +$304 | 0.1% | 138 |
|
2013
Q4 | $1.34M | Sell |
10,062
-41
| -0.4% | -$5.46K | 0.08% | 137 |
|
2013
Q3 | $1.17M | Sell |
10,103
-3,536
| -26% | -$411K | 0.08% | 140 |
|
2013
Q2 | $1.26M | Buy |
+13,639
| New | +$1.26M | 0.09% | 129 |
|